Patient Education
Share your love
Tenpoint and Visus Merge to Advance Eye Care
Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respective ophthalmic therapeutic assets to form a unified entity focused on addressing ocular conditions associated with aging, including presbyopia, cataracts, and geographic atrophy. Key Therapeutics in the Combined…
VSY Biotechnology Appoints Dr. Christian Bach MD
VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has announced the appointment of Dr. Christian Bach as the new Managing Director, effective November 1, 2024. Extensive Experience in Medical Devices Dr. Bach brings over 25 years of…
VisiRose Unveils Non-Invasive Therapy for Keratitis
VisiRose, a newly established company formed in collaboration with Provectus Biopharmaceuticals and the Bascom Palmer Eye Institute (BPEI) at the University of Miami Miller School of Medicine, is advancing the development of Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This…
Fluoxetine Improves Visual Acuity in Adult Amblyopia
A groundbreaking study conducted by researchers from the Eye Research Center, Farabi Eye Hospital, and Tehran University of Medical Sciences has revealed that fluoxetine, a commonly used antidepressant, significantly improves visual acuity (VA) in adults with amblyopia. The study, led…
Nona Biosciences, Kodiak Partner on Ophthalmic Antibodies
Nona Biosciences has announced a strategic partnership with Kodiak Sciences Inc. to advance the development of innovative multi-target antibodies for treating ophthalmic diseases. This collaboration leverages Nona’s proprietary Harbour Mice platform, a cutting-edge technology designed to generate fully human antibodies,…
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology – ca.finance.yahoo.com
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology ca.finance.yahoo.com Source: Author: | Date: 2024-12-11 08:00:00 Source: Author: | Date: 2024-12-11 08:00:00
ViaLase, Moran Eye Center Collaborate on Glaucoma
ViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. This collaboration aims to accelerate glaucoma research by utilizing Moran’s state-of-the-art…
First Inverted Meniscus Optics IOLs by Voptica
*This exclusive article is sponsored by Voptica. The opinions expressed in this article are the sponsor’s own. Intraocular lenses (IOLs) designs are constantly evolving to improve patients’ vision needs. Trifocal diffractive IOLs are designed to achieve good visual acuity at…
Dry Eye Disease Rates High in South America
Researchers from Colombia and Ecuador have identified that dry eye disease (DED)-related symptoms are more prevalent in South America compared to global averages, underscoring significant regional health challenges. The study, led by first author Valentina Loaiza-Guevara from the Facultad de…
Yamane Technique – Intrascleral IOL Fixation
In cataract surgery, the optimal outcome involves implanting an intraocular lens (IOL) within the capsular bag. However, complications such as posterior capsule rupture, congenital lens anomalies, or traumatic injuries can leave patients without adequate capsular support, resulting in aphakia—a condition…